Approval · Notice of Compliance 5407 · 2004
OXYBUTYN: Notice of Compliance 5407
Issued September 21, 2004
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5407
- Date
- September 21, 2004
- Company
- Valeant Canada LpLaval, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Anticholinergic, antispasmodic agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| OXYBUTYN | 02220059 | Cancelled Post Market |
Medicinal ingredients
- OXYBUTYNIN CHLORIDE 5 MG per TAB